Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice-Reference-Cited by-同舟云学术

Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice

Published:2013-10 Issue:10 Volume:1832 Page:1723-1733
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Dolinsky Vernon W.,Chakrabarti Subhadeep,Pereira Troy J.,Oka Tatsujiro,Levasseur Jody,Beker Donna,Zordoky Beshay N.,Morton Jude S.,Nagendran Jeevan,Lopaschuk Gary D.,Davidge Sandra T.,Dyck Jason R.B.

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference39 articles.

1. Global burden of blood-pressure-related disease, 2001;Lawes;Lancet,2008

2. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research;Calhoun;Hypertension,2008

3. Fifty years of Framingham Study contributions to understanding hypertension;Kannel;J. Hum. Hypertens.,2000

4. Pathogenesis and clinical physiology of hypertension;Singh;Cardiol. Clin.,2010

5. Endothelial dysfunction is associated with increased levels of biomarkers in essential hypertension;de la Sierra;J. Hum. Hypertens.,2010

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trajectories of cardiovascular ageing—from molecular mechanisms to clinical implementation;Cardiovascular Research;2024-08-23

2. Biotechnological Breakthroughs in Resveratrol Synthesis and Health Advancements;Current Pharmaceutical Biotechnology;2024-06-27

3. Resveratrol and (-)-Epigallocatechin-3-gallate Regulate Lipid Metabolism by Activating the AMPK Pathway in Hepatocytes;Biology;2024-05-23

4. Resveratrol in the Treatment of Gynecological Cancer: Mechanisms and Therapeutic Potential;Current Medicinal Chemistry;2024-05-03

5. Modulation of the Sirtuin-1 signaling pathway in doxorubicin-induced nephrotoxicity (synergistic amelioration by resveratrol and pirfenidone);Tissue and Cell;2024-04